EP4277624
TRORILUZOLE FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE OF MILD SEVERITY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.1.2022EP published:
14.1.2026EP application number:
22740205.4
EPO information:
European Patent Register
Max expiry date:
16.1.2042
Title in English:
TRORILUZOLE FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE OF MILD SEVERITYLanguage of the patent:
English
Timeline
Today
17.1.2022EP application
14.1.2026EP Publication
Owner
Name:
Biohaven Therapeutics Ltd.Address:
215 Church Street, New Haven, CT 06510, US
Inventor
Name:
CORIC, VladimirAddress:
New Haven, Connecticut 06510, US
Name:
BERMAN, RobertAddress:
New Haven, Connecticut 06510, US
Priority
Number:
202163138669 PDate:
18.1.2021Country:
US
Classification
Categories:
A61K 31/428, A61K 9/48, A61K 39/395, A61P 35/00, A61K 45/06, A61P 25/28